LeMaitre Vascular Cash Flow Statement
NASDAQ: LMATHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LeMaitre Vascular free cash flow
In fiscal 2025, LeMaitre Vascular generated $81.3 million of operating cash flow and spent $6.8 million on capital expenditures. That left free cash flow of $74.5 million, a free-cash-flow margin of 29.8% of revenue. Free cash flow was up 100.4% from the prior year's $37.2 million.
LeMaitre Vascular returned $19.9 million to shareholders: $18.1 million in dividends and $1.8 million in share repurchases, equal to 27% of free cash flow. Free cash flow covered dividend payments 4.1 times.
Summary generated from market data by MetaCap's automated system. Methodology
LeMaitre Vascular cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 57.73M | 44.04M | 30.11M | 20.64M | 26.91M | 21.22M | 17.93M | 22.94M | 17.18M | 10.59M |
| Net Income growth (YoY) | +31.10% | +46.28% | +45.89% | -23.31% | +26.80% | +18.32% | -21.83% | +33.57% | +62.20% | +36.50% |
| Depreciation & Amortization | 10.42M | 9.61M | 9.52M | 9.43M | 11.07M | 8.39M | 5.42M | 4.32M | 4.05M | 3.59M |
| Stock-Based Compensation | 7.83M | 6.57M | 5.32M | 4.17M | 3.48M | 3.02M | 2.64M | 2.35M | 2.26M | 1.68M |
| Change in Working Capital | -521.00K | -8.75M | -6.06M | -6.63M | -2.75M | -850.00K | -1.96M | -1.70M | -1.79M | 606.00K |
| Operating Cash Flow | 81.25M | 44.12M | 36.75M | 25.38M | 35.10M | 34.80M | 14.18M | 19.51M | 22.87M | 16.90M |
| Capital Expenditures | -6.78M | -6.96M | -7.26M | -3.23M | -4.88M | -2.98M | -3.76M | -3.05M | -6.42M | -2.84M |
| Investing Cash Flow | -64.94M | -200.12M | -24.71M | -10.37M | -61.08M | -52.89M | -24.10M | -7.05M | -28.96M | -17.21M |
| Dividends Paid | -18.11M | -14.38M | -12.45M | -10.99M | -9.34M | -7.70M | -6.74M | -5.45M | -4.18M | -3.32M |
| Share Repurchases | -1.82M | -1.72M | -853.00K | -642.00K | -802.00K | -570.00K | -683.00K | -741.00K | -778.00K | -311.00K |
| Financing Cash Flow | -14.54M | 158.10M | -7.13M | -9.23M | 13.70M | 32.16M | -4.62M | -4.42M | 80.00K | -2.58M |
| Net Change in Cash | 2.63M | 1.34M | 5.13M | 5.28M | -12.91M | 14.98M | -14.53M | 7.22M | -5.19M | -3.16M |
| Free Cash Flow | 74.47M | 37.16M | 29.49M | 22.15M | 30.22M | 31.82M | 10.42M | 16.45M | 16.45M | 14.05M |
This table shows 10 annual periods of LeMaitre Vascular's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow LMAT's reporting calendar. What is a cash flow statement?